Catalent | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Agilent USD 300M 76M 2025-04
AstraZeneca USD 3.67B 1.64B 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Bruker USD 31.8M 32.3M 2025-03
Centene USD 1.53B 1.36B 2025-03
Charles River Laboratories USD 74.67M 242.36M 2025-03
Cigna USD 2.01B 291M 2025-03
Danaher USD 1.28B 142M 2025-03
Dentsply International USD 63M 572M 2025-03
Elevance Health USD 3.14B 2.2B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Hologic USD -7000000 236.8M 2025-03
Humana USD 2.01B 2.56B 2025-03
Illumina USD 131M 44M 2025-03
Intuitive Surgical USD 578.1M 156.8M 2025-03
IQVIA Holdings USD 492M 134M 2025-03
J&J USD 13.63B 9.74B 2025-03
Laboratory Of America USD 332.4M 115.9M 2025-03
Lonza CHF 430M 104M 2024-12
McKesson USD 1.59B 367M 2025-03
Merck EUR 1.01B 189M 2025-03
Merck USD 5.87B 1.57B 2025-03
Mettler Toledo International USD 201.94M 112.6M 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Quest Diagnostics USD 346M 15M 2025-03
Repligen USD 6.58M 43.08M 2025-03
Revvity USD 72.23M 46.52M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Thermo Fisher Scientific USD 1.72B 300M 2025-03
UnitedHealth USD 9.1B 1.31B 2025-03
Waters USD 151.74M 140.52M 2025-03
West Pharmaceutical Services USD 107M 52.6M 2025-03



Catalent Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.